The gut-liver axis in hepatobiliary diseases.

Authors:
Ichikawa M; Okada H; Nakamoto N; Taniki N; Chu PS and 1 more

Journal:
Inflamm Regen

Publication Year: 2024

DOI:
10.1186/s41232-023-00315-0

PMCID:
PMC10773109

PMID:
38191517

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Inflamm Regen

Abbreviation: Inflamm Regen

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Mutual interaction of neurons and astrocytes derived from iPSCs with APP V717L mutation developed t…
Supakul S; Murakami R; Oyama C and 7 more (2024) - Transparency Score: 3/6
The gateway reflex regulates tissue-specific autoimmune diseases.
Tanaka Y; Ohki I; Murakami K and 3 more (2024) - Transparency Score: 3/6
Accelerating corneal wound healing using exosome-mediated targeting of NF-κB c-Rel.
Zhao W; He X; Liu R and 1 more (2023) - Transparency Score: 3/6
A disease-specific iPS cell resource for studying rare and intractable diseases.
Saito MK; Osawa M; Tsuchida N and 8 more (2023) - Transparency Score: 3/6
A human induced pluripotent stem cell model from a patient with hereditary cerebral small vessel di…
Qian E; Uemura M; Kobayashi H and 7 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This study was supported in part by the Japan Agency for Medical Research and Development (AMED) under grant number JP21ek0109416, Takeda Science Foundation, and Keio University Medical Fund."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025